Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background Mesio-angular and horizontal mandibular third molars (M3Ms) are a risk factor for the development of dental disease, particularly affecting mandibular second molars (M2Ms). The aim of this study was to gain an insight into patient knowledge, views and opinions on management of disease-free horizontal and mesio-angular M3Ms.Methods Adult patients with at least one horizontal or mesio-angular M3M with an adjacent M2M attending an oral and maxillofacial surgery clinic were invited to participate in a structured survey.Results From 400 responses, 64% (n = 257) of respondents stated they would choose to have their impacted M3M prophylactically removed given the hypothetical scenario that they have never experienced any symptoms from their wisdom tooth. Of patients that never experienced symptoms from their wisdom teeth, 39.1% (n = 43) selected prophylactic removal, compared with 73.8% (n = 214) of patients that had previously experienced symptoms (χ = 40.3; p <0.001). The extent of disease progression significantly influenced patient preference for surgery (χ = 55.173; p <0.001), as did age (χ = 28.28; p <0.001).Conclusion In most cases, symptoms, age and disease experience influenced patients' treatment preferences. These findings support the importance of discussion and shared decision-making in the consent process.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41415-024-7954-yDOI Listing

Publication Analysis

Top Keywords

experienced symptoms
12
mandibular third
8
third molars
8
mesio-angular horizontal
8
horizontal mesio-angular
8
symptoms wisdom
8
patients experienced
8
patient preference
4
preference management
4
management mandibular
4

Similar Publications

Importance: Merkel cell carcinoma (MCC) is typically caused by the Merkel cell polyomavirus (MCPyV) and recurs in 40% of patients. Half of patients with MCC produce antibodies to MCPyV oncoproteins, the titers of which rise with disease recurrence and fall after successful treatment.

Objective: To assess the utility of MCPyV oncoprotein antibodies for early detection of first recurrence of MCC in a real-world clinical setting.

View Article and Find Full Text PDF

IntroductionDaratumumab is a therapeutic cornerstone of the management of multiple myeloma, exerting its anti-myeloma activity through targeting of the cell surface glycoprotein CD38 on plasma cells. While originally given intravenously, the subcutaneous formulation, daratumumab hyaluronidase injection (Dara SC), has been associated with non-inferior efficacy and lower infusion-related reaction rates (IRRs) in the treatment of multiple myeloma and light chain amyloidosis. A noted benefit of Dara SC is a short administration time; however, the optimal observation time post injection to ensure patient safety is unclear from the drug labeling.

View Article and Find Full Text PDF

Purpose: For cancer survivors, self-efficacy is needed to manage the disease and the effects of treatment. The COVID-19 pandemic disrupted cancer-related healthcare, which may have impacted self-management self-efficacy. We investigated self-efficacy reported by cancer survivors during COVID-19, including associations with healthcare disruptions, distress, and general health.

View Article and Find Full Text PDF

Purpose: To compare the efficacy of intraoral (IOPBM) and extraoral photobiomodulation (EOPBM) protocols for the prevention and treatment of oral mucositis (OM) in patients with oral or oropharyngeal squamous cell carcinoma (SCC) to submitted radiotherapy (RT).

Methods: This randomized, blinded, multicenter clinical trial enrolled 58 patients with oral or oropharyngeal SCC, who were allocated into two groups matched by treatment type, clinical stage, and RT modality. Group I (IOPBM) received intraoral photobiomodulation (PBM) with a continuous InGaAlP diode laser (660 nm, 100 mW, 0.

View Article and Find Full Text PDF

[Refeeding syndrome].

Rev Med Suisse

August 2025

Unité de nutrition clinique, Service de gastroentérologie et hépatologie, Hôpitaux universitaires de Genève, 1211 Genève 14.

Refeeding syndrome (RFS), which is often underdiagnosed, is a preventable condition that can be fatal if not managed early. It may occur after nutrition is reintroduced in malnourished patients or those who have experienced a prolonged reduction in food intake. As a result of the metabolic shift from a catabolic to an anabolic state, RFS is characterized by electrolyte disturbances and vitamin deficiencies, which can lead to severe clinical complications.

View Article and Find Full Text PDF